U.S. flag

An official website of the United States government

NM_016180.5(SLC45A2):c.274A>G (p.Ser92Gly) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 12, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001978060.4

Allele description [Variation Report for NM_016180.5(SLC45A2):c.274A>G (p.Ser92Gly)]

NM_016180.5(SLC45A2):c.274A>G (p.Ser92Gly)

Gene:
SLC45A2:solute carrier family 45 member 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5p13.2
Genomic location:
Preferred name:
NM_016180.5(SLC45A2):c.274A>G (p.Ser92Gly)
HGVS:
  • NC_000005.10:g.33984310T>C
  • NG_011691.2:g.5366A>G
  • NM_001012509.4:c.274A>G
  • NM_001297417.4:c.274A>G
  • NM_016180.5:c.274A>GMANE SELECT
  • NP_001012527.2:p.Ser92Gly
  • NP_001284346.2:p.Ser92Gly
  • NP_057264.4:p.Ser92Gly
  • NC_000005.9:g.33984415T>C
  • NM_016180.4:c.274A>G
Protein change:
S92G
Links:
dbSNP: rs755311638
NCBI 1000 Genomes Browser:
rs755311638
Molecular consequence:
  • NM_001012509.4:c.274A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001297417.4:c.274A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_016180.5:c.274A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002262722Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 12, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Clinical evaluation and molecular screening of a large consecutive series of albino patients.

Mauri L, Manfredini E, Del Longo A, Veniani E, Scarcello M, Terrana R, Radaelli AE, Calò D, Mingoia G, Rossetti A, Marsico G, Mazza M, Gesu GP, Cristina Patrosso M, Penco S, Piozzi E, Primignani P.

J Hum Genet. 2017 Feb;62(2):277-290. doi: 10.1038/jhg.2016.123. Epub 2016 Oct 13.

PubMed [citation]
PMID:
27734839

Spectrum Analysis of Albinism Genes in a Large Cohort of Chinese Index Patients.

Wei A, Zhang T, Yuan Y, Qi Z, Bai D, Zhang Y, Zhang Y, Liu T, Huang Q, Yang X, Li W.

J Invest Dermatol. 2022 Jun;142(6):1752-1755.e3. doi: 10.1016/j.jid.2021.11.014. Epub 2021 Nov 24. No abstract available.

PubMed [citation]
PMID:
34838614
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002262722.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 92 of the SLC45A2 protein (p.Ser92Gly). This variant is present in population databases (rs755311638, gnomAD 0.01%). This missense change has been observed in individual(s) with ocular albinism (PMID: 27734839; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 1476655). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC45A2 protein function with a positive predictive value of 80%. This variant disrupts the p.Ser92 amino acid residue in SLC45A2. Other variant(s) that disrupt this residue have been observed in individuals with SLC45A2-related conditions (PMID: 34838614), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024